<code id='4ADF6DA099'></code><style id='4ADF6DA099'></style>
    • <acronym id='4ADF6DA099'></acronym>
      <center id='4ADF6DA099'><center id='4ADF6DA099'><tfoot id='4ADF6DA099'></tfoot></center><abbr id='4ADF6DA099'><dir id='4ADF6DA099'><tfoot id='4ADF6DA099'></tfoot><noframes id='4ADF6DA099'>

    • <optgroup id='4ADF6DA099'><strike id='4ADF6DA099'><sup id='4ADF6DA099'></sup></strike><code id='4ADF6DA099'></code></optgroup>
        1. <b id='4ADF6DA099'><label id='4ADF6DA099'><select id='4ADF6DA099'><dt id='4ADF6DA099'><span id='4ADF6DA099'></span></dt></select></label></b><u id='4ADF6DA099'></u>
          <i id='4ADF6DA099'><strike id='4ADF6DA099'><tt id='4ADF6DA099'><pre id='4ADF6DA099'></pre></tt></strike></i>

          explore

          explore

          author:focus    Page View:2695
          Beth Israel Deaconess Medical Center in Boston
          David L. Ryan/The Boston Globe

          Steward Health Care’s Massachusetts hospitals are on the brink of financial disaster. But in many important ways, Steward’s troubles are just a symptom of a larger crisis engulfing the entire industry.

          While Steward’s for-profit ownership structure put its hospitals at a disadvantage, many health care executives say the state’s entire network of hospitals is approaching a capacity shortage not seen since the early days of the Covid-19 pandemic.

          advertisement

          Industry leaders are calling for urgent action from the Healey administration and the Legislature to help stem the crisis. Even just simplifying the state regulatory bureaucracy and approvals for bringing uninsured patients into the MassHealth system would help, executives say.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          focus

          Novavax promises a turnaround & Lilly roils the obesity market
          Novavax promises a turnaround & Lilly roils the obesity market

          SammyKimballforSTATCanNovavaxfinallygetitright?What’sa“triple-G”drug?AndisNovoNordisklosingground?We

          read more
          Readout LOUD podcast: ALS dilemma, first MASH drug, and more
          Readout LOUD podcast: ALS dilemma, first MASH drug, and more

          Whathappenswhenanapproveddrugdoesn’twork?Whydon’tpatientswantgenetherapy?AndisMASHstillabigdeal?Weco

          read more
          BioMarin wins approval for gene therapy to treat hemophilia A
          BioMarin wins approval for gene therapy to treat hemophilia A

          AdobeTheFoodandDrugAdministrationonThursdayapprovedagenetherapytotreatpeoplewithhemophiliaA,aninheri

          read more

          Readout Newsletter: H5N1 bird flu vaccine, Cytokinetics, Gilead

          Wanttostayontopofthescienceandpoliticsdrivingbiotechtoday? Signup togetourbiotechnewsletterinyourinb